These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3612530)

  • 1. Pharmacokinetics of single chain forms of urokinase-type plasminogen activator.
    Stump DC; Kieckens L; De Cock F; Collen D
    J Pharmacol Exp Ther; 1987 Jul; 242(1):245-50. PubMed ID: 3612530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absence of synergism between tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (scu-PA) and urokinase on clot lysis in a plasma milieu in vitro.
    Collen D; De Cock F; Demarsin E; Lijnen HR; Stump DC
    Thromb Haemost; 1986 Aug; 56(1):35-9. PubMed ID: 3095946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombolytic and pharmacokinetic properties of a recombinant chimeric plasminogen activator consisting of a fibrin fragment D-dimer specific humanized monoclonal antibody and a truncated single-chain urokinase.
    Dewerchin M; Vandamme AM; Holvoet P; De Cock F; Lemmens G; Lijnen HR; Stassen JM; Collen D
    Thromb Haemost; 1992 Aug; 68(2):170-9. PubMed ID: 1412163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological and thrombolytic properties of proenzyme and active forms of human urokinase--II. Turnover of natural and recombinant urokinase in rabbits and squirrel monkeys.
    Collen D; De Cock F; Lijnen HR
    Thromb Haemost; 1984 Aug; 52(1):24-6. PubMed ID: 6495260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative thrombolytic properties of single-chain forms of urokinase-type plasminogen activator.
    Stump DC; Stassen JM; Demarsin E; Collen D
    Blood; 1987 Feb; 69(2):592-6. PubMed ID: 3099862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic effect on thrombolysis of sequential infusion of tissue-type plasminogen activator (t-PA) single-chain urokinase-type plasminogen activator (scu-PA) and urokinase in the rabbit jugular vein thrombosis model.
    Collen D; Stassen JM; De Cock F
    Thromb Haemost; 1987 Oct; 58(3):943-6. PubMed ID: 3124288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Native and non-glycosylated recombinant single-chain urokinase-type plasminogen activator are recognized by different receptor systems on rat parenchymal liver cells.
    van der Kaaden ME; Rijken DC; Groeneveld E; van Berkel TJ; Kuiper J
    Thromb Haemost; 1995 Aug; 74(2):722-9. PubMed ID: 8585013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteolytic cleavage of urokinase-type plasminogen activator by stromelysin-1 (MMP-3).
    Ugwu F; Van Hoef B; Bini A; Collen D; Lijnen HR
    Biochemistry; 1998 May; 37(20):7231-6. PubMed ID: 9585535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition in purified systems and in human plasma of chimaeric plasminogen activators consisting of the NH2-terminal region of tissue-type plasminogen activator and the COOH-terminal region of urokinase-type plasminogen activator.
    Lijnen HR; Nelles L; Van Hoef B; De Cock F; Collen D
    Thromb Haemost; 1988 Oct; 60(2):247-50. PubMed ID: 3146141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the in vitro fibrinolytic activities of low and high molecular weight single-chain urokinase-type plasminogen activator.
    de Munk GA; Groeneveld E; Rijken DC
    Thromb Haemost; 1993 Sep; 70(3):481-5. PubMed ID: 8259553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection of single-chain urokinase-type plasminogen activator (scu-PA) in aprotinin treated cardiac surgical patients undergoing cardiopulmonary bypass.
    Spannagl M; Dooijewaard G; Dietrich W; Kluft C
    Thromb Haemost; 1995 May; 73(5):825-8. PubMed ID: 7482410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrin specific thrombolysis by two-chain urokinase-type plasminogen activator cleaved after arginine 156 by thrombin.
    Abercrombie DM; Buchinski B; Salvato KA; Vovis GF; Stump DC; Broeze RJ
    Thromb Haemost; 1990 Nov; 64(3):426-32. PubMed ID: 2128973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An analysis of the activators of single-chain urokinase-type plasminogen activator (scu-PA) in the dextran sulphate euglobulin fraction of normal plasma and of plasmas deficient in factor XII and prekallikrein.
    Binnema DJ; Dooijewaard G; Turion PN
    Thromb Haemost; 1991 Feb; 65(2):144-8. PubMed ID: 1905069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification and characterization of a novel low molecular weight form of single-chain urokinase-type plasminogen activator.
    Stump DC; Lijnen HR; Collen D
    J Biol Chem; 1986 Dec; 261(36):17120-6. PubMed ID: 3097021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The differential glycosylation of human pro-urokinase from various recombinant mammalian cell lines does not affect activity and binding to PAI-1.
    Sarubbi E; Nolli ML; Robbiati F; Soffientini A; Parenti F; Cassani G
    Thromb Haemost; 1989 Nov; 62(3):927-33. PubMed ID: 2512681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acceleration of the thrombin inactivation of single chain urokinase-type plasminogen activator (pro-urokinase) by thrombomodulin.
    de Munk GA; Groeneveld E; Rijken DC
    J Clin Invest; 1991 Nov; 88(5):1680-4. PubMed ID: 1658049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potentiation by heparin fragments of thrombolysis induced with human tissue-type plasminogen activator or human single-chain urokinase-type plasminogen activator.
    Stassen JM; Juhan-Vague I; Alessi MC; De Cock F; Collen D
    Thromb Haemost; 1987 Oct; 58(3):947-50. PubMed ID: 2829381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and characterization of clustered charge-to-alanine mutants of low M(r) single-chain urokinase-type plasminogen activator.
    Ueshima S; Holvoet P; Lijnen HR; Nelles L; Seghers V; Collen D
    Thromb Haemost; 1994 Jan; 71(1):134-40. PubMed ID: 8165632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of the low-density lipoprotein receptor-related protein (LRP) in the plasma clearance and liver uptake of recombinant single-chain urokinase-type plasminogen activator in rats.
    van der Kaaden ME; Rijken DC; Kruijt JK; van Berkel TJ; Kuiper J
    Thromb Haemost; 1997 Apr; 77(4):710-7. PubMed ID: 9134648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Properties of chimeric (tissue-type/urokinase-type) plasminogen activators obtained by fusion at the plasmin cleavage site.
    Colucci M; Cavallo LG; Agnelli G; Mele A; Bürgi R; Heim J; Semeraro N
    Thromb Haemost; 1993 May; 69(5):466-72. PubMed ID: 8391727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.